Device Trial Radar · NCT02241642
Safety and Performance Study of Large Hole Vascular Closure Device
Last checked: Nov 20, 2026Latest source record: Feb 1, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
65
Actual
Start
Oct 2013
Primary completion
Nov 2016
Study completion Nov 2017
Sponsor
- Lead sponsor
- Vivasure Medical LimitedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 16, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this Clinical Investigation is to validate that the clinical use of the VIVASURE CLOSURE DEVICE™ is safe for the operator, patient and third parties, and to confirm its performance to percutaneously close femoral arterial puncture sites in the range of 18-24 F, post endovascular procedures. This is a non-inferiority study based on safety. Safety will be assessed by incidence and severity of major complication rates directly related to the VIVASURE CLOSURE DEVICE™ up to 3 months from implantation is no worse than those associated with cut-down and sutured close.
Conditions
- Percutaneous Common Femoral Artery Arteriotomy Closure
Interventions
VIVASURE CLOSURE DEVICE™Device
Large hole vascular closure device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary EndpointTime frame: 3 months
Locations
9 sites in 4 countries. Site status is shown where the registry gives one.
University Hospital Antwerp (UZA)
Edegem, Belgium
The Charité - Universitätsmedizin
Berlin, Germany
Vivantes Klinikum im Friedrichshain
Berlin, Germany
6 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.